Literature DB >> 9647380

Alendronate-associated esophagitis: endoscopic and pathologic features.

A Ribeiro1, K R DeVault, J T Wolfe, M E Stark.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9647380     DOI： 10.1016/s0016-5107(98)70256-1

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN： 0016-5107            Impact factor:   9.427


× No keyword cloud information.
  12 in total

Review 1.  Presbyesophagus: a reappraisal.

Authors:  Kenneth R DeVault
Journal:  Curr Gastroenterol Rep       Date:  2002-06

Review 2.  Alendronate: an update of its use in osteoporosis.

Authors:  M Sharpe; S Noble; C M Spencer
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Oral bisphosphonates and upper gastrointestinal toxicity: a study of cancer and early signals of esophageal injury.

Authors:  N E Morden; J C Munson; J Smith; T A Mackenzie; S K Liu; A N A Tosteson
Journal:  Osteoporos Int       Date:  2014-10-28       Impact factor: 4.507

4.  Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans.

Authors:  Derek Lin; Jennifer R Kramer; David Ramsey; Abeer Alsarraj; Gordana Verstovsek; Massimo Rugge; Paola Parente; David Y Graham; Hashem B El-Serag
Journal:  Am J Gastroenterol       Date:  2013-07-16       Impact factor: 10.864

Review 5.  Safety of long-term bisphosphonate therapy for the management of osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

Review 6.  Long-term safety concerns of antiresorptive therapy.

Authors:  Jie Zhang; Kenneth G Saag; Jeffrey R Curtis
Journal:  Rheum Dis Clin North Am       Date:  2011-08       Impact factor: 2.670

7.  Alendronate-induced esophagitis in an elderly woman.

Authors:  Victoria Gómez; Shu-Yuan Xiao
Journal:  Int J Clin Exp Pathol       Date:  2008-06-20

Review 8.  What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates.

Authors:  David Y Graham
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

9.  Endoscopic comparison of alendronate alone and the enteric-coated alendronate with calcitriol combination in postmenopausal Korean females.

Authors:  Ji Oh Mok; Chan Hee Jung; Chul Hee Kim; Chang Beom Ryu; Yeo Joo Kim; Sang Jin Kim; Hyeong Kyu Park; Kyo Il Suh; Myung Hi Yoo; Dong-Won Byun
Journal:  Korean J Intern Med       Date:  2013-10-29       Impact factor: 2.884

Review 10.  Postmenopausal osteoporosis. What have we learned since the introduction of bisphosphonates?

Authors:  Sumapa Chaiamnuay; Kenneth G Saag
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 9.306
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.